Opioid receptor: Difference between revisions
m Protected "Opioid receptor": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}}{{VB}} | |||
==Overview== | |||
'''Opioid receptors''' are a group of [[G-protein coupled receptor]]s with [[opioid]]s as [[ligand]]s. The [[endogenous]] [[opioids]] are [[dynorphin]]s, [[enkephalin]]s, [[endorphin]]s, endomorphins and nociceptin/orphanin FQ. The opioid receptors are ~40% identical to [[somatostatin]] [[receptor (biochemistry)|receptor]]s (SSTRs). | '''Opioid receptors''' are a group of [[G-protein coupled receptor]]s with [[opioid]]s as [[ligand]]s. The [[endogenous]] [[opioids]] are [[dynorphin]]s, [[enkephalin]]s, [[endorphin]]s, endomorphins and nociceptin/orphanin FQ. The opioid receptors are ~40% identical to [[somatostatin]] [[receptor (biochemistry)|receptor]]s (SSTRs). | ||
Line 12: | Line 16: | ||
|- | |- | ||
| [[mu Opioid receptor]] (μ) || OP<sub>3</sub> || μ<sub>1</sub>, μ<sub>2</sub>, μ<sub>3</sub> | | [[mu Opioid receptor]] (μ) || OP<sub>3</sub> || μ<sub>1</sub>, μ<sub>2</sub>, μ<sub>3</sub> | ||
|- | |||
| [[Nociceptin Opioid receptor]] || OP<sub>4</sub> || ORL<sub>1</sub></sub> | |||
|} | |} | ||
Line 25: | Line 31: | ||
An IUPHAR subcommittee has suggested that appropriate terminology for the 3 typical (μ, δ, κ) and the atypical (nociceptin) receptors, should be MOR, DOR, KOR and NOR respectively. | An IUPHAR subcommittee has suggested that appropriate terminology for the 3 typical (μ, δ, κ) and the atypical (nociceptin) receptors, should be MOR, DOR, KOR and NOR respectively. | ||
===Major subtypes=== | |||
There are four major subtypes of opioid receptors:<ref name="pmid16402099">{{cite journal | author = Corbett AD, Henderson G, McKnight AT, Paterson SJ | title = 75 years of opioid research: the exciting but vain quest for the Holy Grail | journal = Br. J. Pharmacol. | volume = 147 Suppl 1 | issue = Suppl 1| pages = S153–62 | year = 2006 | pmid = 16402099 | doi = 10.1038/sj.bjp.0706435 | pmc = 1760732 }}</ref> | |||
{| class="wikitable" | |||
|- | |||
! Receptor | |||
! Subtypes | |||
! Location<ref name="Stein C, Schäfer M, Machelska H (2003)">{{cite journal | author = Stein C, Schäfer M, Machelska H | title = Attacking pain at its source: new perspectives on opioids | journal = Nat. Med. | volume = 9 | issue = 8 | pages = 1003–8 |date=August 2003 | pmid = 12894165 | doi = 10.1038/nm908 }}</ref><ref name="stoppain">{{cite book | last = Fine PG, Portenoy RK | title = A Clinical Guide to Opioid Analgesia |url= |format= |accessdate= |edition= |series= |volume= |date= |year= 2004 |month= | publisher = McGraw Hill |location= |language= |isbn= |oclc= |doi= |id= |pages= |chapter = Chapter 2: The Endogenous Opioid System |chapterurl = http://www.stoppain.org/pcd/_pdf/OpioidChapter2.pdf }}</ref> | |||
! Function<ref name="Stein C, Schäfer M, Machelska H (2003)"/><ref name="stoppain"/> | |||
|- | |||
| [[opioid receptor|delta (δ)]] <BR>DOR<BR> OP<sub>1</sub> <sup>(I)</sup> || δ<sub>1</sub>, δ<sub>2</sub> || | |||
*[[Brain]] | |||
**[[Pons|Pontine]] nuclei | |||
**[[Amygdala]] | |||
**[[Olfactory bulbs]] | |||
**deep [[Cerebral cortex|Cortex]] | |||
* Peripheral sensory neurons | |||
|| | |||
*[[Analgesia]] | |||
*[[Antidepressant]] effects | |||
* [[convulsion|Convulsant]] effects | |||
*[[Physical dependence]] | |||
* Perhaps of mu-opioid receptor-mediated respiratory depression | |||
|- | |||
| [[opioid receptor|kappa (κ)]] <BR>KOR<BR> OP<sub>2</sub> <sup>(I)</sup> || κ<sub>1</sub>, κ<sub>2</sub>, κ<sub>3</sub> || | |||
*[[Brain]] | |||
**[[Hypothalamus]] | |||
**[[Periaqueductal gray]] | |||
**[[Claustrum]] | |||
*[[Spinal cord]] | |||
**[[Substantia gelatinosa of Rolando|substantia gelatinosa]] | |||
* Peripheral sensory neurons | |||
|| | |||
*Analgesia | |||
*[[Anticonvulsant]] effects | |||
*[[Dissociative]] & [[Deliriant]] effects | |||
*[[Fluid balance|Diuresis]] | |||
*[[Dysphoria]] | |||
*[[Miosis]] | |||
*[[Neuroprotection]] | |||
*[[Sedation]] | |||
|- | |||
| [[opioid receptor|mu (μ)]] <BR>MOR<BR> OP<sub>3</sub> <sup>(I)</sup> || μ<sub>1</sub>, μ<sub>2</sub>, μ<sub>3</sub> || | |||
*[[Brain]] | |||
**[[Cerebral cortex|Cortex]] (laminae III and IV) | |||
**[[Thalamus]] | |||
** striosomes | |||
**[[Periaqueductal gray]] | |||
** Rostral ventromedial medulla | |||
*[[Spinal cord]] | |||
**[[Substantia gelatinosa of Rolando|substantia gelatinosa]] | |||
* Peripheral sensory neurons | |||
*[[Intestinal tract]] | |||
|| '''μ<sub>1</sub>''': | |||
*[[Analgesia]] | |||
*[[Physical dependence]] | |||
'''μ<sub>2</sub>''': | |||
*[[Respiratory depression]] | |||
*[[Miosis]] | |||
*[[Euphoria]] | |||
*Reduced [[gastrointestinal tract|GI]] [[peristalsis|motility]] | |||
*[[Physical dependence]] | |||
'''μ<sub>3</sub>''': | |||
*Possible vasodilation | |||
|- | |||
| [[Nociceptin receptor]] <BR> NOP<BR>OP<sub>4</sub> || ORL<sub>1</sub> || | |||
*[[Brain]] | |||
**[[Cerebral cortex|cortex]] | |||
**[[Amygdala]] | |||
**[[Hippocampus]] | |||
**[[Septal nuclei]] | |||
**[[Habenula]] | |||
**[[Hypothalamus]] | |||
*[[Spinal cord]] | |||
|| | |||
*Anxiety | |||
*Depression | |||
*Appetite | |||
*Development of tolerance to μ agonists | |||
|} | |||
<small>(I). Name based on order of discovery</small> | |||
==References== | ==References== |
Latest revision as of 23:11, 13 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Vidit Bhargava, M.B.B.S [2]
Overview
Opioid receptors are a group of G-protein coupled receptors with opioids as ligands. The endogenous opioids are dynorphins, enkephalins, endorphins, endomorphins and nociceptin/orphanin FQ. The opioid receptors are ~40% identical to somatostatin receptors (SSTRs).
Types of receptors
There are three major subtypes of opioid receptors: [1]
Greek letter name | Name based on order of discovery | Subtypes |
delta Opioid receptor (δ) | OP1 | δ1, δ2 |
kappa Opioid receptor (κ) | OP2 | κ1, κ2, κ3 |
mu Opioid receptor (μ) | OP3 | μ1, μ2, μ3 |
Nociceptin Opioid receptor | OP4 | ORL1 |
Sigma receptors (σ) were once considered to be opioid receptors, but are not usually currently classified as such.
The receptors were named using the first letter of the first ligand that was found to bind to them. Morphine was the first chemical shown to bind to mu receptors. The first letter of the drug morphine is `m', but in biochemistry there is a tendency to use Greek letters, thus turning the 'm' to μ. Similarly a drug known as ketocyclazocine was first shown to attach itself to kappa receptors.[2]
The opioid receptor types are ~70% identical with differences located at N and C termini. The μ receptor (the μ represents morphine) is perhaps the most important. It is thought that the G protein binds to the third intracellular loop of the opioid receptors. Both in mice and humans the genes for the various receptor subtypes are located on different chromosomes.
Separate subtypes have been identified in human tissue. Research has so far failed to identify the genetic evidence of the subtypes, and it is thought that they arise from post-translational modification of cloned receptor types.[3]
An additional opioid receptor has been identified and cloned based on homology with the cDNA. This receptor is known as the nociceptin receptor or ORL 1 receptor.
An IUPHAR subcommittee has suggested that appropriate terminology for the 3 typical (μ, δ, κ) and the atypical (nociceptin) receptors, should be MOR, DOR, KOR and NOR respectively.
Major subtypes
There are four major subtypes of opioid receptors:[4]
Receptor | Subtypes | Location[5][6] | Function[5][6] |
---|---|---|---|
delta (δ) DOR OP1 (I) |
δ1, δ2 |
|
|
kappa (κ) KOR OP2 (I) |
κ1, κ2, κ3 |
|
|
mu (μ) MOR OP3 (I) |
μ1, μ2, μ3 |
|
μ1:
μ2: μ3:
|
Nociceptin receptor NOP OP4 |
ORL1 |
|
(I). Name based on order of discovery
References
- ↑ Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006).75 years of opioid research: the exciting but vain quest for the Holy Grail. Brit. J. Pharmacol.147, S153–S162
- ↑ http://opioids.com/narcotic-drugs/chapter-3.html
- ↑ Fries, DS (2002). Opioid Analgesics. In Williams DA, Lemke TL. Foye's Principles of Medicinal Chemistry (5 ed.). Philadelphia: Lippincott Williams & Wilkins. ISBN 0-683-30737-1.
- ↑ Corbett AD, Henderson G, McKnight AT, Paterson SJ (2006). "75 years of opioid research: the exciting but vain quest for the Holy Grail". Br. J. Pharmacol. 147 Suppl 1 (Suppl 1): S153–62. doi:10.1038/sj.bjp.0706435. PMC 1760732. PMID 16402099.
- ↑ 5.0 5.1 Stein C, Schäfer M, Machelska H (August 2003). "Attacking pain at its source: new perspectives on opioids". Nat. Med. 9 (8): 1003–8. doi:10.1038/nm908. PMID 12894165.
- ↑ 6.0 6.1 Fine PG, Portenoy RK (2004). "Chapter 2: The Endogenous Opioid System" (PDF). A Clinical Guide to Opioid Analgesia. McGraw Hill.
See also
External links
- IUPHAR GPCR Database - Opioid Receptors
- Opioid+Receptors at the US National Library of Medicine Medical Subject Headings (MeSH)
- Calculated spatial position of mu-opioid receptor in the lipid bilayer, inactive state with antagonist and active state with agonist
de:Opioidrezeptor fi:Opioidireseptori Template:WikiDoc Sources